Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Bitetto

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology|December 15, 2010
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCCCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
BMC Cancer|February 21, 2014
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical managementLuca Faloppi, Mario Scartozzi, Maristella Bianconi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2013
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcomeStefano Ginanni Corradini, Maria Siciliano, Lucia Parlati, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2026
Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated CirrhosisEnrico Pompili, Giulia Iannone, Salvatore Piano, et al.
JHEP Reports : Innovation in Hepatology|December 6, 2024
Real-world experience with long-term albumin in patients with cirrhosis and ascitesEnrico Pompili, Giacomo Zaccherini, Salvatore Piano, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology|December 15, 2010
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCCCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
BMC Cancer|February 21, 2014
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical managementLuca Faloppi, Mario Scartozzi, Maristella Bianconi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2013
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcomeStefano Ginanni Corradini, Maria Siciliano, Lucia Parlati, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2026
Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated CirrhosisEnrico Pompili, Giulia Iannone, Salvatore Piano, et al.
JHEP Reports : Innovation in Hepatology|December 6, 2024
Real-world experience with long-term albumin in patients with cirrhosis and ascitesEnrico Pompili, Giacomo Zaccherini, Salvatore Piano, et al.
Pageof 7